Independent Janoshik Analytical reports for Chameleon Peptides tested batches, with direct lab-hosted links for identity, amount, purity, endotoxin, and heavy metals where those tests were ordered.
68
Public Janoshik Reports
99.4%
Avg Batch Purity
58
Screening Cards
4.9/5
Trustpilot Rating
Tested by Janoshik Analytical – documented through Chameleon BatchTrace – last updated August 7, 2026
01 Identity
Mass spectrometry or linked method confirms submitted material matches labeled compound.
02 Purity
HPLC purity shows the percentage of target compound detected in submitted sample.
03 Amount
Reported quantity reflects what Janoshik detected in the tested vial or sample.
04 Screens
Endotoxin, heavy-metal, and sterility results are shown where specific testing exists.
Going-forward testing standard: New production batches tested from July 2026 forward receive identity, purity, and sterility testing, with report links posted as received. Older ledger cards reflect actual listed report scopes.
5-Amino-1MQ
40mg · Batch B002
Current documentation
Proves identityChecks amountProves purityEndotoxin screenedRead each report by listed scope
Testing scope5-Amino-1MQ 40mg Batch B002 has Janoshik identity, amount, and endotoxin reporting posted for the current 40mg inventory. The ID/amount report does not include a purity percentage.
Testing scope5-Amino-1MQ 5mg Batch B001 has Janoshik amount reporting posted for the current 5mg inventory. This older report does not include purity or endotoxin results.
Testing scopeAOD9604 5mg Batch B002 has Janoshik identity, amount, purity, and endotoxin reporting posted for the current 5mg inventory. Vanguard full-panel image previews are now posted for purity, mass, identity, endotoxin, sterility, and heavy metals; the public PDF link is pending.
Testing scopeB12 10mg/10mL Batch B002 has Janoshik Vitamin B12 analysis posted for the current single-vial inventory. The report lists cyanocobalamin concentration only; it is not a purity, sterility, or endotoxin report.
Testing scopeThe 10-vial kit uses the same B12 10mg/10mL Batch B002 inventory and Janoshik Vitamin B12 analysis as the single-vial option. The report lists cyanocobalamin concentration only; it is not a purity, sterility, or endotoxin report.
Representative batch sampleBatch B002 was sampled at the 10mg strength. Identity, purity, and endotoxin results are shown here as representative batch testing; the measured-mass value is the sampled 10mg vial, not a 5mg fill measurement.
Blend testing scopeBPC-157 + TB-500 10mg+10mg Batch B003 has Janoshik identity and measured amount reporting for both components. Vanguard full-panel image previews are posted below for B003 purity, component mass, identity, endotoxin, sterility, and heavy metals; the public PDF link is pending.
PurityNot included · Amount/composition report only
Blend testing scopeBPC-157 + TB-500 5mg+5mg Batch B002 has Janoshik identity and measured amount reporting for both components. The blend report does not include individual HPLC purity percentages, endotoxin, heavy metals, or sterility.
Testing scopeJanoshik #209743 documents B003 identity and component amounts. Vanguard full-panel image previews are posted below for B003 purity, component mass, identity, endotoxin, sterility, and heavy metals; the public PDF link is pending.
Testing scopeThe 10-vial kit uses the same B003 inventory and testing context as the single-vial option: Janoshik #209743 is the active ID/amount report, and Vanguard full-panel image previews are posted below while the public PDF link is pending.
Testing scopeDSIP Batch B002 current 10mg inventory has Janoshik identity, amount, purity, and endotoxin reports posted. Vanguard full-panel image previews are now posted for purity, mass, identity, endotoxin, sterility, and heavy metals; the public PDF link is pending.
Historical strengthThe 15mg option is Batch B001 historical inventory and is currently out of stock. Current available DSIP inventory is 10mg Batch B002.
Split-batch testing scopeCurrent 50mg GHK-Cu inventory is represented by Batch B002A and B002B Janoshik ID, amount, purity, and endotoxin reports. Match vial batch labeling and QR/report links when reviewing COAs.
Composition testing scopeGLOW 70mg is the nominal blend label size. Janoshik #194120 reports component amounts for the submitted Batch B002 vial, not individual HPLC purity percentages for each component.
Composition testing scopeThe 10-vial kit uses the same GLOW Batch B002 inventory and Janoshik composition/endotoxin reports as the single-vial option. Component amounts are report values for the submitted vial, not separate per-component purity percentages.
Testing scopeGLP-1C 10mg Batch B002 is documented by Janoshik #209745 for HPLC purity and measured mass. Vanguard full-panel image previews are now posted for purity, mass, identity, endotoxin, sterility, and heavy metals; the public PDF link is pending.
Testing scopeGLP-1C 5mg Batch B001 is documented by Janoshik #112812 for the current 5mg inventory. The newer 10mg report is separate and does not replace this 5mg-specific report.
Testing statusOut of stock · Prior 5mg batch is archived
Unavailable strengthGLP-1S 5mg is out of stock. Prior 5mg COAs remain available in the BatchTrace archive and should not be used to verify the current 10mg Batch B002 inventory.
Testing scopeGLP-1T 10mg Batch B002A/B has Janoshik identity, amount, purity, and corrected endotoxin reports posted for the sampled 10mg inventory. The 10mg strength is currently out of stock.
Representative batch sampleBatch B002A/B was sampled at the 10mg strength. Identity, purity, and endotoxin results are shown here as representative batch testing; the measured-mass values are the sampled 10mg vials, not a 20mg fill measurement.
Representative batch sampleBatch B002A/B was sampled at the 10mg strength. Identity, purity, and endotoxin results are shown here as representative batch testing; the measured-mass values are the sampled 10mg vials, not a 30mg fill measurement.
Representative batch sampleBatch B002A/B was sampled at the 10mg strength. Identity, purity, and endotoxin results are shown here as representative batch testing; the measured-mass values are the sampled 10mg vials, not a 40mg fill measurement.
Representative batch sampleBatch B002A/B was sampled at the 10mg strength. Identity, purity, and endotoxin results are shown here as representative batch testing; the measured-mass values are the sampled 10mg vials, not a 5mg fill measurement.
Representative batch sampleBatch B002A/B was sampled at the 10mg strength. Identity, purity, and endotoxin results are shown here as representative batch testing; the measured-mass values are the sampled 10mg vials, not a 60mg fill measurement.
Why this is listed as 7mgB003 7mg was originally submitted for testing as 10mg. Janoshik testing showed the vial content was under the intended 10mg fill, so this batch is listed as 7mg to accurately reflect the tested amount.
Testing scopeIpamorelin 10mg Batch B003 is documented by Janoshik #209747 for HPLC purity, measured mass, and identity. Vanguard full-panel image previews are posted for purity, mass, identity, endotoxin, sterility, and heavy metals; the public PDF link is pending.
Testing scopeIpamorelin 5mg current inventory remains Batch B002 and is documented by Janoshik #152451. The newer B003 report applies to 10mg only and does not replace this 5mg-specific report.
Blend testing scopeKLOW Batch B004 is a blend. Janoshik remains posted as supporting component mass/identity context, and Vanguard full-panel image previews are now posted for purity, component mass, identity, endotoxin, sterility, and heavy metals; the public PDF link is pending.
Janoshik pending – HPLC purityPending · Janoshik identity, purity, and mass report not yet published
Janoshik pending – Measured massPending · Janoshik identity, purity, and mass report not yet published
Janoshik pending – IdentityPending · Janoshik identity, purity, and mass report not yet published
Vanguard full panel pending – HPLC purityPending · Vanguard full-panel report not yet published
Vanguard full panel pending – Measured massPending · Vanguard full-panel report not yet published
Vanguard full panel pending – IdentityPending · Vanguard full-panel report not yet published
Vanguard full panel pending – EndotoxinsPending · Vanguard full-panel report not yet published
Vanguard full panel pending – SterilityPending · Vanguard full-panel report not yet published
Vanguard full panel pending – Heavy metalsPending · Vanguard full-panel report not yet published
Testing scopeKPV 10mg Batch B003 has initial BioChex identity, measured mass, and purity reporting posted for Lot 112455. Janoshik identity/purity/mass testing is pending, and Vanguard full-panel testing is pending.
Testing scopeL-Carnitine 6000mg/10ml Batch B004 has Vanguard Laboratory identity, measured concentration, endotoxin, sterility, and heavy-metals reporting posted as image previews. The public PDF link is pending.
Testing scopeThe 10-vial kit uses the same L-Carnitine 6000mg/10ml Batch B004 inventory and Vanguard Laboratory full-panel report as the single-vial option.
Composition testing scopeLipo-C Complex Batch B002 has Janoshik composition and endotoxin reports posted. The composition report notes L-Arginine was not detected in the tested sample, so that result is shown explicitly here.
Vanguard sterility pendingJanoshik remains posted as the main identity/purity report. Vanguard image previews are posted for purity, mass, identity, endotoxin, and heavy metals; sterility is still pending, and the public PDF link is pending.
Representative batch sampleBatch B002 was sampled at the 10mg strength. Identity and purity results are shown here as representative batch testing; the measured-mass value is the sampled 10mg vial, not a 20mg fill measurement.
Representative batch sampleBatch B002 was sampled at the 10mg strength. Identity and purity results are shown here as representative batch testing; the measured-mass value is the sampled 10mg vial, not a 40mg fill measurement.
Representative batch sampleBatch B002 was sampled at the 500mg strength. Identity and amount results are shown here as representative batch testing; the reported 520.65 mg result is the sampled 500mg vial, not a 1000mg fill measurement.
Testing scopeJanoshik #212709 and Vanguard V260722-10 014 list the submitted sample as SS-31 50mg. Chameleon lists this storefront strength as 35mg; match vial batch B001 and the posted report previews. Vanguard adds full-panel purity, mass, identity, endotoxin, sterility, and heavy-metals screening; the public PDF link is pending.
Representative batch sampleBatch B002 was sampled at the 5mg strength. Identity, purity, and endotoxin results are shown here as representative batch testing; the measured-mass value is the sampled 5mg vial, not a 10mg fill measurement.
Representative batch sampleBatch B002 was sampled at the 5mg strength. Identity, purity, and endotoxin results are shown here as representative batch testing; the measured-mass value is the sampled 5mg vial, not a 10mg fill measurement.
Representative batch sampleBatch B002 was sampled at the 10mg strength. Identity, purity, and measured-mass results are shown here as representative batch testing; the measured-mass value is the sampled 10mg vial, not a 5mg fill measurement.
Testing scopeTB-500 10mg Batch B003 has Horizon Analytical identity, purity, measured mass, and endotoxin reports posted for the current selected strength.
Testing scopeTesamorelin 10mg Batch B005 has Vanguard Laboratory identity, HPLC purity, measured mass, endotoxin, sterility, and heavy-metals reporting posted for the current 10mg inventory.
Representative batch sampleBatch B002 was sampled at the 5mg strength. Identity, purity, and endotoxin results are shown here as representative batch testing; the measured-mass value is the sampled 5mg vial, not a 10mg fill measurement.
Historical ID + amount (blend)Historical Batch B001 blend report: CJC-1295 (mod GRF 1-29) 5.59 mg; ipamorelin 4.54 mg. Purity not included on this blend report.
Historical ID + amount + purityHistorical Batch B001 report: kisspeptin-10 5.48 mg; 99.579% purity. Current inventory is 10mg Batch 002 with separate testing.
